BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4356872)

  • 1. Letter: Protection of cytomegalovirus-infected cells by IgG antibody.
    Diosi P; Herzog G
    Br Med J; 1973 Sep; 3(5881):638. PubMed ID: 4356872
    [No Abstract]   [Full Text] [Related]  

  • 2. The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin.
    Westmoreland D; St Jeor S; Rapp F
    J Immunol; 1976 Jun; 116(6):1566-70. PubMed ID: 178801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
    Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
    J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Hormonal protection of cytomegalovirus-infected cell.
    Diosi P; David C
    Lancet; 1973 Dec; 2(7844):1503-4. PubMed ID: 4129350
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of cytomegalovirus infection in the failure of native arteriovenous fistula.
    Dzabic M; Bojakowski K; Kurzejamska E; Styczynski G; Andziak P; Söderberg-Nauclér C; Religa P
    Clin Microbiol Infect; 2012 Jan; 18(1):E5-7. PubMed ID: 22070535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoperoxidase antibody to human cytomegalovirus-induced membrane antigen assay in the absence of interfering immunoglobulin G receptors.
    Haikin H; Sarov I
    Intervirology; 1980; 14(3-4):155-9. PubMed ID: 6263819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of cytomegalovirus and host balance in elderly subjects.
    Musiani M; Zerbini M; Zauli D; Cometti G; La Placa M
    J Clin Pathol; 1988 Jul; 41(7):722-5. PubMed ID: 2842379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.
    Aiba N; Shiraki A; Yajima M; Oyama Y; Yoshida Y; Ohno A; Yamada H; Takemoto M; Daikoku T; Shiraki K
    Viral Immunol; 2017 Sep; 30(7):500-507. PubMed ID: 28598267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts.
    Keller R; Peitchel R; Goldman JN; Goldman M
    J Immunol; 1976 Mar; 116(3):772-7. PubMed ID: 176272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunological reactivity to two major antigens of homologous and AD169 human cytomegalovirus strains during primary infection in renal transplant patients.
    Rossier E; Miller H; Dal Monte P; Boccuni C; Landini MP
    New Microbiol; 1993 Jan; 16(1):1-9. PubMed ID: 8385731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
    Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
    J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens.
    Baalawi F; Robertson P; Rawlinson WD
    Pathology; 2010; 42(6):578-80. PubMed ID: 20854078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.
    Lobo CA; Cowan KM; Trautman R; Hanson RP
    Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
    Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
    Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus serological status in patients with interstitial lung diseases.
    Dworniczak S; Ziora D; Basta L; Piwowarska G; Jastrzebski D; Oklek K; Kozielski J
    Przegl Epidemiol; 2003; 57(3):431-7. PubMed ID: 14682161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on IgA of the guinea-pig.
    Coe JE
    Immunology; 1972 Mar; 22(3):333-45. PubMed ID: 4112734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
    J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated and humoral immune responses or renal transplant recipients with cytomegalovirus infections.
    Lopez C; Simmons RL; Park BH; Najarian JS; Good RA
    Clin Exp Immunol; 1974 Apr; 16(4):565-73. PubMed ID: 4377553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological studies in asymptomatic congenital cytomegalovirus infection.
    Bluestone R; Goldberg LS; Tucker SM; Stern H
    Arch Dis Child; 1973 Sep; 48(9):738-40. PubMed ID: 4354781
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.